FDA Approves New Drug Treatment for Long-Term Pain Relief after
FDA Approves New Drug Treatment for Long-Term Pain Relief after Shingles Attacks
The Food and Drug Administration (FDA) has approved the approval of Qutenza (capsaicin) 8% patch, a medicated skin patch that relieves the pain of post-herpetic neuralgia (PHN), a serious complication that can occur after a bout with shingles.